Tenax Therapeutics
(TENX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 19,494 | 8,234 | 11,053 | 32,729 | 9,868 |
| Operating Income | -19,494 | -8,234 | -11,053 | -32,728 | -9,868 |
| Interest Expense | 23 | 24 | 4 | 1 | 2 |
| Other Income | 1,915 | 547 | 9 | 255 | 18 |
| Pre-tax Income | -17,602 | -7,711 | -11,048 | -32,474 | -9,851 |
| Net Income Continuous | -17,602 | -7,711 | -11,048 | -32,474 | -9,851 |
| Net Income | $-17,602 | $-7,711 | $-11,048 | $-32,474 | $-9,851 |
| EPS Basic Total Ops | -1.15 | -31.04 | -600.71 | -2,524.80 | -1,520.00 |
| EPS Basic Continuous Ops | -1.15 | -31.09 | -600.72 | -2,524.73 | -1,520.57 |
| EPS Diluted Total Ops | -1.15 | -31.04 | -600.71 | -2,524.80 | -1,520.00 |
| EPS Diluted Continuous Ops | -1.15 | -31.09 | -600.72 | -2,524.73 | -1,520.57 |
| EPS Diluted Before Non-Recurring Items | -1.15 | -31.04 | N/A | -2,528.00 | -2,128.00 |
| EBITDA(a) | $-19,494 | $-8,226 | $-10,939 | $-32,610 | $-9,746 |